drugset / Trial / NCT01288196
A Safety, Tolerability, Pharmacokinetics, and Immunogenicity Study of CNTO 6785 in Healthy Volunteers
RandomizedSingle-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, blood levels, and immune responses of CNTO 6785 after administration to healthy adult volunteers.
Timeline
- Start
- 2011-02
- Primary completion
- 2011-08
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CNTO 6785 | Monoclonal antibody | 1 mg/kg | Intravenous |
| Subject | CNTO 6785 | Monoclonal antibody | 3 mg/kg | Intravenous |
| Subject | CNTO 6785 | Monoclonal antibody | 10 mg/kg | Intravenous |
Indications
No indication recorded.